Showing results (201-210 of 233) with videos related to

Sort By:
Pageof 24
British Journal of Cancer|June 15, 2013
Does thyroid-stimulating hormone influence the prognosis of patients with endometrial cancer? A multicentre trialV Seebacher, G Hofstetter, S Polterauer, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 29, 1998
Peritoneum and tissues of the female reproductive tract as physiological sources of CA-125A G Zeimet, F A Offner, E Müller-Holzner, et al.
Archives of Gynecology and Obstetrics|January 23, 2018
The use of PIPAC (pressurized intraperitoneal aerosol chemotherapy) in gynecological oncology: a statement by the "Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR)", the Swiss and Austrian AGO, and the North-Eastern German Society of Gynaecologic OncologyA M Dueckelmann, D Fink, P Harter, et al.
British Journal of Cancer|March 29, 2000
Interferon-gamma in the first-line therapy of ovarian cancer: a randomized phase III trialG H Windbichler, H Hausmaninger, W Stummvoll, et al.
Archives of Gynecology and Obstetrics|February 16, 2018
Correction to: The use of PIPAC (pressurized intraperitoneal aerosol chemotherapy) in gynecological oncology: a statement by the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) Kommission Ovar, AGO Study Group, North-Eastern German Society of Gynaecologic Oncology (NOGGO), AGO Austria and AGO SwitzerlandA M Dueckelmann, D Fink, P Harter, et al.
Geburtshilfe Und Frauenheilkunde|March 5, 2016
Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria and AGO Switzerland Regarding the Use of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian CancerP Harter, A du Bois, S Mahner, et al.
Gene Therapy|July 26, 2002
Determination of molecules regulating gene delivery using adenoviral vectors in ovarian carcinomasA G Zeimet, E Müller-Holzner, A Schuler, et al.
Anticancer Research|February 24, 2001
Peritoneal mesothelial cells as a significant source of ascitic immunostimulatory protein 90KA G Zeimet, S Stadlmann, C Natoli, et al.
Cancer Research|November 1, 1990
Gamma-interferon reduces expression of the protooncogene c-erbB-2 in human ovarian carcinoma cellsC Marth, E Müller-Holzner, E Greiter, et al.
The American Journal of Pathology|December 14, 1999
Basic fibroblast growth factor synthesis by human peritoneal mesothelial cells: induction by interleukin-1M V Cronauer, S Stadlmann, H Klocker, et al.
Pageof 24